Trials / Active Not Recruiting
Active Not RecruitingNCT06739850
Identification of Risk Phenotypes for Sarcopenia Using DXA WBC, Anthropometric and MA Among Young Adults
Identification of Risk Phenotypes for Sarcopenia Using DXA Whole Body Composition, Anthropometric and Muskuloskeltal Analysis Among Young Adults
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 221 (actual)
- Sponsor
- Superior University · Academic / Other
- Sex
- All
- Age
- 15 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
This cross-sectional study aims to identify risk phenotypes for sarcopenia among young adults using Dual-energy X-ray Absorptiometry (DXA) for whole-body composition analysis, along with anthropometric and musculoskeletal assessments. Sarcopenia, characterized by the loss of muscle mass and strength, is a growing concern, particularly among the aging population.
Detailed description
However, early identification in young adults can allow for preventive strategies to improve long-term health outcomes. This study, involving 221 participants aged 15 to 35, focuses on assessing the correlation between DXA-derived body composition, musculoskeletal fitness, and anthropometric measurements with sarcopenia risk. Primary outcome measures include DXA imaging and dynamometry for body composition and strength evaluation, while secondary outcomes focus on detailed anthropometric and musculoskeletal analyses. By addressing early risk factors in younger populations, this research hopes to enhance understanding of sarcopenia's development and support early intervention strategies. Data collection is conducted at the Center of Nuclear Medicine in Lahore, Pakistan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Identification of Risk Phenotypes of Sarcopenia | Sarcopenia is a condition characterized by progressive loss of skeletal muscle mass, strength, and function, often associated with aging. Traditionally, it is studied in older populations, but your focus is on identifying its early manifestations in young adults, potentially offering a window for prevention. |
Timeline
- Start date
- 2024-02-28
- Primary completion
- 2024-05-31
- Completion
- 2025-03-01
- First posted
- 2024-12-18
- Last updated
- 2024-12-18
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06739850. Inclusion in this directory is not an endorsement.